Niche CDMO confirms spray drying for highly potent drugs

Idifarma’s GMP spray drying technology is now operational for highly potent drugs up to category 4 OEL/OEB

Idifarma’s new GEA Niro Mobile Minor spray drying equipment in operation

Idifarma, a specialist in niche and highly potent products has installed the GEA Niro Mobile Minor equipment, making the company one of only three companies in the world offering this type of contract development and manufacturing spray drying service.

The spanish contract development and manufacturing organisation (CDMO) will house the equipment in a new dedicated area in its 4000 ft2 EU GMP plant.

The equipment is now installed and qualified and will give Idifarma spray drying capacity for niche commercial products and clinical batches.

Luis Oquiñena, General Manager and co-founder of Idifarma, said: “We are at the forefront of spray drying technology, providing contract manufacturing services for intermediate products and for oral solid drugs through to finished dosage forms.”

“This is the latest strategic investment for Idifarma and is driven by significant client demand as the market looks for spray drying solutions to improve the bioavailability of poorly soluble drugs. Idifarma is proud to support our customers’ spray drying projects at different scales and contribute to accelerated drug development and manufacturing timelines.”

This announcement follows investment in both serialisation and capsule filling capabilities and strengthens Idifarma’s position as a specialised contract partner for the development and manufacturing of oral solid dosage forms, including high potency compounds and niche pharmaceuticals requiring small commercial and clinical batches.

Companies